Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: Effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones

Obesity Surgery

Volumn 24, Issue 5, 2014, Pages 718-726

  Bradnova, Olga ^a,d   Kyrou, Ioannis ^b   Hainer, Vojtech ^a   Vcelak, Josef ^a   Halkova, Tereza ^a,d   Sramkova, Petra ^c   Dolezalova, Karin ^c   Fried, Martin ^c   McTernan, Philip ^b   Kumar, Sudhesh ^b   Hill, Martin ^a   Kunesova, Marie ^a   Bendlova, Bela ^a   Vrbikova, Jana ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Centre for Treatment of Obesity and Metabolic Disorders   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Gastric plication; Morbid obesity; Type 2 diabetes

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OBESTATIN; TRIACYLGLYCEROL; GASTROINTESTINAL HORMONE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LAPAROSCOPIC GREATER CURVATURE PLICATION; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEST MEAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; COMPLICATION; EVALUATION STUDY; GASTROPLASTY; HOMEOSTASIS; LAPAROSCOPY; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PROCEDURES; TIME;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONES; GASTROPLASTY; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; LAPAROSCOPY; MIDDLE AGED; OBESITY, MORBID; POSTPRANDIAL PERIOD; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84898046593     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1143-4     Document Type: Article

References (38)

1. Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet. 2012;379(9833):2300-11. PMID: 22683132.
2. Fried M, Dolezalova K, Buchwald JN, et al. Laparoscopic greater curvature plication (LGCP) for treatment of morbid obesity in a series of 244 patients. Obes Surg. 2012;22(8):1298-307. PMID: 22648797.
3. Mui WL, Lee DW, Lam KK, et al. Laparoscopic greater curve plication in Asia: initial experience. Obes Surg. 2013;23(2):179-83. PMID: 22968832.
4. Niazi M, Maleki AR, Talebpour M. Short-term outcomes of laparoscopic gastric plication in morbidly obese patients: importance of postoperative follow-up. Obes Surg. 2013;23(1):87-92. PMID: 23007660.
5. Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg. 2011;21(11):1657-63. PMID: 21898042.
6. Ramos A, Galvao Neto M, Galvao M, et al. Laparoscopic greater curvature plication: initial results of an alternative restrictive bariatric procedure. Obes Surg. 2010;20(7):913-8. PMID: 20407932.
7. Brethauer SA, Harris JL, Kroh M, et al. Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis. 2011;7(1):15-22. PMID: 21144804.
8. Abdelbaki TN, Huang CK, Ramos A, et al. Gastric plication for morbid obesity: a systematic review. Obes Surg. 2012;22(10):1633-9. PMID: 22960951.
9. Lee DY, Guend H, Park K, et al. Outcomes of laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding in adolescents. Obes Surg. 2012;22(12):1859-64. PMID: 22923312.
10. Montero PN, Stefanidis D, Norton HJ, et al. Reported excess weight loss after bariatric surgery could vary significantly depending on calculation method: a plea for standardization. Surg Obes Relat Dis. 2011;7(4):531-4. PMID: 21159563.
11. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17(5):565-8. PMID: 17658011.
12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. PMID: 3899825.
13. Meloun M, Hill M, Militký J, et al. Transformation in the PC-aided biochemical data analysis. Clin Chem Lab Med. 2000;38(6):553-9. PMID: 10987205.
14. Meloun M, Hill M, Militký J, et al. New methodology of influential point detection in regression model building for the prediction of metabolic clearance rate of glucose. Clin Chem Lab Med. 2004;42(3):311-22. PMID: 15080566.
15. Scott WR, Batterham RL. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol. 2011;301(1):R15-27. Review. PMID: 21474429.
16. Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740-8. PMID: 22354457.
17. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401-7. PMID: 18376181.
18. Zizzari P, Hassouna R, Grouselle D, et al. Physiological roles of preproghrelin-derived peptides in GH secretion and feeding. Peptides. 2011;32(11):2274-82. PMID: 21530598.
19. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001;86(10):5083-6. PMID: 11600590.
20. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006;3(5):379-86. PMID: 16679295.
21. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-39. Review. PMID: 17928588.
22. Paschetta E, Hvalryg M, Musso G. Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders. Obes Rev. 2011;12(10):813-28. Review. PMID: 21815989.
23. Romero F, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26(8):2231-9. PMID: 22302537.
24. Dimitriadis E, Daskalakis M, Kampa M, et al. Alterations in gut hormones after laparoscopic sleeve gastrectomy: a prospective clinical and laboratory investigational study. Ann Surg. 2013;257(4):647-54. PMID: 23108120.
25. Papamargaritis D, le Roux CW, Sioka E, et al. Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2013;9(2):192-201. PMID: 23183113.
26. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236-42. PMID: 15273546.
27. Tsoli M, Chronaiou A, Kehagias I, Kalfarentzos F, Alexandrides TK. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis. 2013;9:667-77
28. Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy - a "food limiting" operation. Obes Surg. 2008;18(10):1251-6. PMID: 18663545.
29. Gaylinn BD, Thorner MO. Luminal influences to orchestrate gastroenterological hormone secretion: the fat, long-chain fatty acid, cholecystokinin, glucagon-like peptide 1 axis. J Clin Endocrinol Metab. 2010;95(2):503-4. PMID: 20133469.
30. Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308. PMID: 17635890.
31. Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298(3):309-16. PMID: 17635891.
32. Teno S, Uto Y, Nagashima H, et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care. 2000;23(9):1401-6. PMID: 10977041.
33. Leonetti F, Capoccia D, Coccia F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment. Arch Surg. 2012;147(8):694-700. PMID: 22508671.
34. Moustarah F, Gilbert A, Després JP, et al. Impact of gastrointestinal surgery on cardiometabolic risk. Curr Atheroscler Rep. 2012;14(6):588-96. PMID: 23054664.
35. Stefater MA, Sandoval DA, Chambers AP, Wilson-Pérez HE, Hofmann SM, Jandacek R, Tso P, Woods SC, Seeley RJ. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology. 2011 Sep;141(3):939-949.e1-4. PMID: 21699773.
36. Kotidis EV, Koliakos GG, Baltzopoulos VG, et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment - a prospective study. Obes Surg. 2006;16(11):1425-32. PMID: 17132406.
37. Chandarana K, Gelegen C, Karra E, et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes. 2011;60(3):810-8. PMID: 21292870.
38. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479-85. PubMed PMID: 18430778.